Base4 Biotechnology
PrivateMomentum
Top 50%
of companies Caplight tracks
Company Overview
Base4 Biotechnology is a biotechnology company that develops RNA-modulating small molecule drugs using its proprietary DART (Dynamic Atomic-Resolution RNA Targeting) platform.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Base4 Biotechnology Comparables
Compare Base4 Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Serna Bio | 91% | |
| Ribometrix | 88% | |
| RiboNova | 86% |
Base4 Biotechnology Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors grew 136% MoM to 399.
- Jun 17, 2026
Monthly visitors increased 63% MoM.
Base4 Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Base4 Biotechnology's valuation, stock price, and market status.
Is Base4 Biotechnology a public or private company?
Base4 Biotechnology is a private company.
What is the current stock price of Base4 Biotechnology?
Base4 Biotechnology is a private company, so its shares have no public market price. Caplight tracks Base4 Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Base4 Biotechnology worth (valuation)?
Valuation information for Base4 Biotechnology is not publicly available.
Can I buy Base4 Biotechnology stock?
Base4 Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Base4 Biotechnology's last funding round?
Funding round information for Base4 Biotechnology is not publicly available.
Who are the main investors in Base4 Biotechnology?
Investor information for Base4 Biotechnology is not publicly disclosed.
Will Base4 Biotechnology IPO soon?
No public IPO plans have been announced for Base4 Biotechnology.
How can I track Base4 Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades in Base4 Biotechnology's shares on secondary markets.